Selected article for: "diabetic nephropathy and viral entry"

Author: Mourad, Diane; Azar, Nadim S.; Azar, Sami T.
Title: Diabetic Nephropathy and COVID-19: The Potential Role of Immune Actors
  • Cord-id: qjncr0v1
  • Document date: 2021_7_21
  • ID: qjncr0v1
    Snippet: Nowadays, type II diabetes mellitus, more specifically ensuing diabetic nephropathy, and severe COVID-19 disease are known to be closely associated. The exact mechanisms behind this association are less known. An implication for the angiotensin-converting enzyme 2 remains controversial. Some researchers have started looking into other potential actors, such as neuropilin-1, mitochondrial glutathione, vitamin D, and DPP4. In particular, neuropilin-1 seems to play an important role in the underlyi
    Document: Nowadays, type II diabetes mellitus, more specifically ensuing diabetic nephropathy, and severe COVID-19 disease are known to be closely associated. The exact mechanisms behind this association are less known. An implication for the angiotensin-converting enzyme 2 remains controversial. Some researchers have started looking into other potential actors, such as neuropilin-1, mitochondrial glutathione, vitamin D, and DPP4. In particular, neuropilin-1 seems to play an important role in the underlying mechanism linking COVID-19 and diabetic nephropathy. We suggest, based on the findings in this review, that its up-regulation in the diabetic kidney facilitates viral entry in this tissue, and that the engagement of both processes leads to a depletion of neuropilin-1, which was demonstrated to be strongly associated with the pathogenesis of DN. More studies are needed to confirm this hypothesis, and research should be directed towards elucidating the potential roles of all these suggested actors and eventually discovering new therapeutic strategies that could reduce the burden of COVID-19 in patients with diabetic nephropathy.

    Search related documents:
    Co phrase search for related documents
    • ace angiotensin ii and acute kidney injury: 1
    • ace angiotensin ii and acute kidney injury aki: 1
    • ace angiotensin ii and additional receptor: 1
    • ace angiotensin ii and adipose tissue: 1, 2, 3
    • ace receptor and acei captopril: 1
    • ace receptor and acei enzyme inhibitor: 1
    • ace receptor and actin cytoskeleton: 1
    • ace receptor and acute kidney injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • ace receptor and acute kidney injury aki: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • ace receptor and additional receptor: 1
    • ace receptor and adipose tissue: 1, 2, 3, 4, 5
    • ace receptor and long duration: 1
    • acei enzyme inhibitor and acute kidney injury: 1
    • actin cytoskeleton and additional receptor: 1